Biocon renames Irish step-down subsidiary as Biocon Biologics Ireland
Move aligns global biologics identity under the Biocon Biologics brand
Move aligns global biologics identity under the Biocon Biologics brand
The announcement follows a record-setting $1.2 million accelerated LineaDNA order
This deal marks a major step for Alteogen as it pushes its Hybrozyme platform deeper into the oncology market
The grant will fund ten new J.MD projects over the next three years, targeting multiple global health threats
The investment in land is Rs. 19.85 crore
The new company aims to transform cutting-edge, highly scalable technologies into innovative drug discovery platforms
Senores Pharmaceuticals (SPI) acquired 51% stake in Zoraya Pharmaceuticals
The entity will undertake the installation, operation, and maintenance of sewage treatment plants
The $700 million project is part of Roche’s $50 billion investment in US manufacturing, infrastructure and R&D
Subscribe To Our Newsletter & Stay Updated